MacroGenics Accounts Payable from 2010 to 2024

MGNX Stock  USD 3.24  0.03  0.93%   
MacroGenics Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable will likely drop to about 6.1 M in 2024. Accounts Payable is the amount MacroGenics owes to suppliers or vendors for products or services received but not yet paid for. It represents MacroGenics' short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2011-12-31
Previous Quarter
5.2 M
Current Value
6.6 M
Quarterly Volatility
3.2 M
 
Yuan Drop
 
Covid
Check MacroGenics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MacroGenics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.3 M, Interest Expense of 1.5 M or Selling General Administrative of 37 M, as well as many indicators such as Price To Sales Ratio of 9.98, Dividend Yield of 0.0 or PTB Ratio of 4.1. MacroGenics financial statements analysis is a perfect complement when working with MacroGenics Valuation or Volatility modules.
  
Check out the analysis of MacroGenics Correlation against competitors.
For more information on how to buy MacroGenics Stock please use our How to Invest in MacroGenics guide.

Latest MacroGenics' Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of MacroGenics over the last few years. An accounting item on the balance sheet that represents MacroGenics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of MacroGenics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. MacroGenics' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MacroGenics' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Very volatile
   Accounts Payable   
       Timeline  

MacroGenics Accounts Payable Regression Statistics

Arithmetic Mean5,959,376
Geometric Mean4,983,868
Coefficient Of Variation65.20
Mean Deviation2,990,963
Median4,308,000
Standard Deviation3,885,379
Sample Variance15.1T
Range13.8M
R-Value0.06
Mean Square Error16.2T
R-Squared0
Significance0.83
Slope52,397
Total Sum of Squares211.3T

MacroGenics Accounts Payable History

20246.1 M
20236.4 M
20224.9 M
202115.5 M
2020M
20194.3 M
2018M

About MacroGenics Financial Statements

MacroGenics investors use historical fundamental indicators, such as MacroGenics' Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MacroGenics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable6.4 M6.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for MacroGenics Stock Analysis

When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.